 |
 |
I just learned of the dramatic and promising results of your cancer drug for Parkinson’s patients. I also learned it costs $10,000 a month. The drug’s developer, Dr. Brian Druker, received a taxpayer funded NIH grant to develop it. Why does Novartis charge $120,000 a year for this drug? Would’t Novartis make a big profit if millions of people could actually afford it? Parkinson’s is not a rare disease. There is also a big market in Alzheimer’s and I understand there are going to be trials with 2 cancer drugs with other neurodegeneral diseases besides PD. A response would be greatly appreciated. Thank you. Rayilyn Brown Past Director AZNPF Arizona Chapter National Parkinson Foundation ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn